Lightnews — Scholar-powered news

Characterizing financial risk from out‐of‐pocket expenditures across dementia stages

3

Peter Neumann @peterneumann11.bsky.social · 16d

New Tufts-CEVR research led by @pattysynnott.bsky.social highlights:
- high out-of-pocket costs of older adults living with dementia
- financial risks increase in advanced dementia states.

alz-journals.onlinelibrary.wiley.com/doi/10.1002/... #Alzheimers #dementia

INTRODUCTION Older adults with dementia incur considerable out-of-pocket (OOP) health care expenses, but it is unclear how their financial burden differs by dementia stage. METHODS We identified 2...

alz-journals.onlinelibrary.wiley.com

1 1 2

Peter Neumann @peterneumann11.bsky.social · 25d

In this just published paper in Value in Health led by Feng Xie and colleagues, we reviewed the published cost-effectiveness evidence for the 15 drugs selected for IPAY 2027 Medicare negotiations.

@djvanness.bsky.social @ankurfactorial.bsky.social
www.valueinhealthjournal.com/article/S109...

Cost Effectiveness of the 15 Drugs Selected for IPAY 2027 CMS Drug Price Negotiation

To analyze published cost-effectiveness analyses (CEAs) for the 15 drugs selected for the Initial Price Applicability Year 2027 by the Centers for Medicare and Medicaid Services (CMS).

www.valueinhealthjournal.com

1 2 1

Reposted by Peter Neumann

Dan Ollendorf @dano-hta.bsky.social · Aug 4

@icer-review.bsky.social @tuftscevr.bsky.social @peterneumann11.bsky.social @pattysynnott.bsky.social

Dan Ollendorf @dano-hta.bsky.social · Aug 4

New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...

Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal

The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...

www.healthaffairs.org

2 7

Peter Neumann @peterneumann11.bsky.social · Jul 29

Welcome, Dave!

CEVR @tuftscevr.bsky.social · Jul 29

CEVR is thrilled to welcome David Strutton, PhD, as a Senior Fellow! Dr. Strutton brings 30+ years of global leadership in health policy, biopharma, and HTA. His expertise in real-world evidence and access strategy will be a tremendous asset.

Read more at: tinyurl.com/3bz9te3p

David Strutton, PhD, to Join Tufts-CEVR as Senior Fellow - Center for the Evaluation of Value and Risk in Health

David Strutton, PhD, to Join Tufts-CEVR as Senior Fellow - Center for the Evaluation of Value and Risk in Health

1

Reposted by Peter Neumann

CEVR @tuftscevr.bsky.social · Jul 29

CEVR is thrilled to welcome David Strutton, PhD, as a Senior Fellow! Dr. Strutton brings 30+ years of global leadership in health policy, biopharma, and HTA. His expertise in real-world evidence and access strategy will be a tremendous asset.

Read more at: tinyurl.com/3bz9te3p

VUMC researchers host international fellows for economic evaluation, decision science training

Peter Neumann @peterneumann11.bsky.social · Jul 29

Excited to announce that David Strutton, Ph.D., a distinguished leader in healthcare policy, biopharmaceuticals, #vaccines, and #healtheconomics is joining Tufts-CEVR as a Senior Fellow.

Announcement here: cevr.tuftsmedicalcenter.org/news/david-s... @tuftscevr.bsky.social

4

Reposted by Peter Neumann

CEVR @tuftscevr.bsky.social · Jul 23

Great application of our CEA Registry at the #Vanderbilt Center for Health Economic Modeling: 11 international fellows from #LMICs used the Registry to conduct CEAs of public health interventions.

Read more at: tinyurl.com/88varaue

@peterneumann11.bsky.social #ISPOR

Vanderbilt recently hosted 11 international fellows to provide training to help them address public health issues in their home countries.

Value assessment for health services and procedures: a call to action in a new political climate

2 2

Reposted by Peter Neumann

CEVR @tuftscevr.bsky.social · Jul 21

New in JCER: CEVR’s Meng Li and @peterneumann11.bsky.social call for more value assessment of health services/procedures. These interventions are ~70% of health care spending but are often implemented without robust evidence and, unlike drugs, can cost more over time.

Read: tinyurl.com/ycxrppby

Health Economics and Outcomes Research (HEOR) Certificate Program - Tufts CTSI

Reposted by Peter Neumann

CEVR @tuftscevr.bsky.social · Jul 18

Two weeks left to apply: Earn your #HEOR Certificate online from @tufts.edu with globally-recognized faculty like @peterneumann11.bsky.social, @dano-hta.bsky.social, James Chambers, and more from CEVR. Apply today!

Deadline is Aug. 1.

tinyurl.com/pr6drkhf

#RWE #pharma

Overview The Tufts University Graduate School of Biomedical Sciences (GSBS) Clinical and Translational Science (CTS) Graduate Program is delighted to offer an accredited Certificate Program in Health ...

In remembrance of John Iglehart - Center for the Evaluation of Value and Risk in Health

2 2

Reposted by Peter Neumann

CEVR @tuftscevr.bsky.social · Jul 14

Larry Mose, MSc is today’s #CEARegistry Summer fellow. Larry earned his MSc from @york.ac.uk and hopes to work in the field of #HEOR.

Our thanks to the @moorefound.bsky.social ‬for funding the CEA Registry Fellowship program!‬‬

2 3

Reposted by Peter Neumann

CEVR @tuftscevr.bsky.social · Jul 7

1/ How closely do health plans’ drug #utilizationmanagement (UM) policies align with #clinicalguidelines? CEVR and NPC examined policies for 389 drug-indication pairs from 18 commercial insurers. Here’s a thread on what we found:

1 3 3

Peter Neumann @peterneumann11.bsky.social · Jun 23

Some personal reflections about John Iglehart (1939-1975), Founding Editor of Health Affairs.

cevr.tuftsmedicalcenter.org/news/in-reme... @tuftscevr.bsky.social

CEVR Welcomes 2025 CEA Registry Summer Fellows - Center for the Evaluation of Value and Risk in Health

2

Peter Neumann @peterneumann11.bsky.social · Jun 20

New Tufts-CEVR paper in the J of Alzheimer's Disease, led by Paige Lin, provides updated health utility estimates for persons with AD and their caregivers across disease stages and settings.

journals.sagepub.com/doi/10.1177/... @tuftscevr.bsky.social @pattysynnott.bsky.social #Alzheimers

1 3

Peter Neumann @peterneumann11.bsky.social · Jun 17

Pleased to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, supported by the Gordon and Betty Moore Foundation.

cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social

CEVR Welcomes 2025 CEA Registry Summer Fellows - Center for the Evaluation of Value and Risk in Health

Reposted by Peter Neumann

CEVR @tuftscevr.bsky.social · Jun 16

CEVR is thrilled to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, which is supported by the @moorefound.bsky.social. Stay tuned over the next two months for featured posts about each fellow!

More details at: cevr.tuftsmedicalcenter.org/news/2025-ce...

CBO’s Panel of Health Advisers, 2025

1 1 5

Peter Neumann @peterneumann11.bsky.social · Jun 7

Congrats, Mel!

CEVR @tuftscevr.bsky.social · Jun 5

In recognition of her expertise in health economics, CEVR Senior Fellow Melanie Whittington, PhD, has been appointed to the Congressional Budget Office (#CBO) 2025 Panel of Health Advisors. Congratulations Melanie!

Read the CBO announcement at tinyurl.com/ms7j82c6

CBO announces the members of its Panel of Health Advisers for the coming year.

Use of Large Language Models to Extract Cost-Effectiveness Analysis Data: A Case Study

3

Reposted by Peter Neumann

CEVR @tuftscevr.bsky.social · Jun 6

New in Value in Health: three former CEA Registry Summer Fellows (Xujun Gu, Hanwen Zhang, and Divya Patil) and U of Maryland's Julia Slejko used the CEA Registry to explore the utility of AI-assisted data extraction.

Read at tinyurl.com/37mh5n6m

Cost-effectiveness analyses (CEAs) generate extensive data that can support much health economic research. However, manual data collection is time-consuming and prone to errors. Development in Artific...

Research Ideas for CEA Registry Users - Center for the Evaluation of Value and Risk in Health

Reposted by Peter Neumann

CEVR @tuftscevr.bsky.social · May 29

ISPOR and CEVR are partnering to offer free premium access to the CEA Registry for students + academic/government researchers in LMICs.

Unlock data from 14,000+ cost-effectiveness studies, advanced tools, and more.

More at: tinyurl.com/5y3vpsz3

#HEOR #GlobalHealth #ISPOR

ISPOR Student and LMIC Researcher Members to Receive Free CEA Registry Access under Tufts-CEVR / ISPOR Partnership - Center for the Evaluation of Value and Risk in Health

1 3 4

Peter Neumann @peterneumann11.bsky.social · May 29

We're excited to announce Tufts-CEVR's new partnership with ISPOR to provide free, premium access to the CEA Registry for ISPOR members who are students or researchers in LMICs.

More detail here: cevr.tuftsmedicalcenter.org/news/cevr-is...

@djvanness.bsky.social @tuftscevr.bsky.social

Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States - PharmacoEconomics

2 3

Peter Neumann @peterneumann11.bsky.social · May 14

With @tuftscevr.bsky.social colleagues #ISPORAnnual in Montreal.

1 1 4

Peter Neumann @peterneumann11.bsky.social · Apr 19

Thanks to all my wonderful Tufts-CEVR colleagues for putting on another great annual meeting! Proud to work with you!

@dano-hta.bsky.social @brianreid.bsky.social @tuftscevr.bsky.social @mollytoba.bsky.social

3 6

Peter Neumann @peterneumann11.bsky.social · Apr 9

Congrats!

CEVR @tuftscevr.bsky.social · Apr 9

CEVR is thrilled to announce the winners of our 7th Annual Cost-Effectiveness Paper of the Year Award.

Best CEA — Anita Brogan et al. Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States (tinyurl.com/mw5ff646)

#CEA #HEOR

Objective Cabotegravir long-acting (CAB–LA) administered every 2 months was approved in the USA as pre-exposure prophylaxis (PrEP) for individuals at risk of acquiring human immunodeficiency virus (HI...

Can Prevention Save Money?

1 1

Peter Neumann @peterneumann11.bsky.social · Apr 7

This right question about prevention: not whether it saves money, but whether it is worth the cost.

tinyurl.com/3ezrrvm4 @tuftscevr.bsky.social #health #prevention

This JAMA Forum discusses some key considerations for addressing the question of whether and when prevention interventions are worth the cost.